机构维持医疗器械行业“领先大市”评级，医疗器械ETF（562600）持仓股济民健康连收5个涨停板

Group 1 - The medical device sector experienced fluctuations, with the medical device ETF (562600) declining by 0.21%. However, Ji Min Health saw a strong surge, hitting the daily limit for five consecutive trading days, while Tuo Jing Life and An Jie Si also rose by over 6% [1] - In terms of capital flow, the medical device ETF (562600) had net inflows for four out of the last five trading days, accumulating 42.82 million yuan, and nine out of the last ten trading days, totaling 68.02 million yuan [1] - The recently released "Implementation Opinions on Promoting the Innovation and Development of Brain-Machine Interface Industry" aims for breakthroughs in key technologies by 2027, establishing advanced technical, industrial, and standard systems [1] Group 2 - The implementation opinions emphasize increased support for key products like implantable brain-machine interface medical devices, including expedited registration guidance and priority support [1] - According to Xinda Securities, the centralized procurement in the medical device sector is changing the competitive landscape, benefiting leading companies and accelerating domestic substitution [1] - The medical device industry is expected to transition from scale expansion to a higher level of development, with opportunities arising from technological platformization, AI diagnostics, and consumer healthcare extensions [1] Group 3 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index [2] - This ETF selects 100 representative listed companies in core medical fields, with the medical device sector accounting for 89.34% of the index, highlighting its concentrated structure [2]